ISRCTN83582782已完成未知
32-week, multicentre, open, randomised, two-way cross-over, clinical trial comparing insulin glargine (HOE 901) in combination with insulin lispro and neutral protamine Hagedorn in combination with regular human insulin in subjects with type one diabetes mellitus on a meal-time and basal insulin regimen
Sanofi-aventis (UK)0 个研究点目标入组 71 人开始时间: 2007年4月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 71
研究概览
简要总结
2006 Results article in http://www.ncbi.nlm.nih.gov/pubmed/16492212 2008 Results article in http://www.ncbi.nlm.nih.gov/pubmed/18339977
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Men and women, aged 18 to 65 years
- •2. Type one diabetes mellitus as shown by C-peptide deficient status (less than 0.10 nmol/L when plasma glucose is greater than 4.5 mmol/L)
- •3. More than one year on a daily multiple insulin injection regimen
- •4. Experience in Self Monitoring of Blood Glucose (SMBG), interpretation of SMBG results and insulin dose adjustments
- •5. HbA1c greater than 7.0% and less than 9.5% at visit one
- •6. Willingness to actively adjust the insulin doses in order to achieve the target blood glucose levels and to perform SMBG profiles using the Accutrend Sensor Complete on a regular basis as specified in the study protocol
- •7. Women of childbearing potential are to be using adequate contraceptive protection
排除标准
- •1. Treatment with blood-glucose-lowering drugs other than insulin in the last eight weeks before screening visit (visit one)
- •2. Use of an investigational drug other than insulin in the last six months before study entry, or use of an investigational insulin in the last four weeks before study entry
- •3. Diabetic retinopathy with surgical treatment (laser photocoagulation or vitrectomy) in the three months before study entry or which may require surgical treatment within three months of study entry as evidenced by retino-screening within the last 12 months
- •4. History of repeated severe hypoglycaemia with unconsciousness within the last two years
- •5. Night shift workers
- •6. Pancreatectomised subjects
- •7. Clinically relevant cardiovascular, hepatic, neurologic, endocrine, or other major systemic disease making implementation of the protocol or interpretation of the study results difficult
- •8. History of drug or alcohol abuse
- •9. Pregnant (as determined by pregnancy blood test at visit one) or breast-feeding women
- •10. Impaired hepatic function, as shown by but not limited to Serum Glutamic Pyruvic Transaminase (SGPT) (ALanine AminoTransferase
- •[ALAT]) or Serum Glutamic-Oxaloacetic Transaminase (SGOT) (ASpartate AminoTransferase [ASAT]) above 2 x the upper limit of normal measured at visit one
- •11. Impaired renal function, as shown by but not limited to serum creatinine greater than 177 µmol/L (greater than 2.0 mg/dL) measured at visit one
- •12. Mental condition rendering the subject unable to understand the nature, scope and possible consequences of the study
- •13. Evidence of an uncooperative attitude
- •14. Inability to attend clinical visits
- •15. Known employee of sanofi-aventis
研究者
相似试验
已完成
不适用
A multi-centre double blind randomised controlled trial of aspirin and/or folate supplementation for the prevention of recurrent colorectal adenomasRecurrent colorectal adenomasMalignant neoplasm of rectosigmoid junctionCancerISRCTN22669537Cancer Research UK (CRUK) (UK)1,000
已完成
2 期
Cediranib maleate with or without gefitinib in treating patients with recurrent or progressive glioblastomaBrain TumourMalignant neoplasm of brainCancerISRCTN00549973niversity College London (UK)38
已完成
不适用
A multi-centre, randomised, double-blind trial studying the effect of misoprostol on the outcome of intra-uterine inseminatioPregnancy, prostaglandin, misoprostol, vaginal suppository, Intra-Uterine Insemination (IUI)Pregnancy and ChildbirthPregnancyISRCTN76424181niversity Hospital Ghent (Belgium)217
已完成
不适用
A MultiCentre randomised Trial of the outcome, acceptability and cost-effectiveness of family therapy and multi-family day treatment compared with inpatient care and outpatient family therapy for Adolescent Anorexia NervosaAnorexia Nervosa (in adolescents)Mental and Behavioural DisordersAnorexia nervosaISRCTN11275465The Health Foundation (UK)400
已完成
不适用
SWITCH - Sensing With Insulin pump Therapy to Control HbA1cNutritional, Metabolic, EndocrineType 1 diabetes mellitusISRCTN09806152Medtronic International Trading Sarl (Switzerland)160